Baxter International Stock Price, Forecast & Analysis (NYSE:BAX)

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International declared a quarterly dividend on Tuesday, July 16th. Shareholders of record on Friday, August 30th will be given a dividend of $0.22 per share on Tuesday, October 1st. This represents a $0.88 dividend on an annualized basis and a yield of 1.09%. The ex-dividend date is Thursday, August 29th. View Baxter International's Dividend History.

Baxter International announced that its board has authorized a stock buyback plan on Tuesday, November 13th 2018, which permits the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 6.1% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's board believes its shares are undervalued.

Baxter International Inc (NYSE:BAX) released its quarterly earnings data on Wednesday, October, 31st. The medical instruments supplier reported $0.80 EPS for the quarter, beating the consensus estimate of $0.74 by $0.06. The medical instruments supplier had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.79 billion. Baxter International had a return on equity of 22.99% and a net margin of 13.80%. The firm's revenue was up 2.2% compared to the same quarter last year. During the same period last year, the company posted $0.64 EPS. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Baxter International.

14 brokerages have issued 12 month target prices for Baxter International's stock. Their forecasts range from $75.00 to $109.00. On average, they anticipate Baxter International's share price to reach $90.46 in the next twelve months. This suggests a possible upside of 12.0% from the stock's current price. View Analyst Price Targets for Baxter International.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 4 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Media headlines about BAX stock have trended somewhat negative recently, InfoTrie reports. The research firm ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Baxter International earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned news articles about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Baxter International.

Baxter International saw a decrease in short interest during the month of October. As of October 31st, there was short interest totalling 5,490,000 shares, a decrease of 16.9% from the September 30th total of 6,610,000 shares. Based on an average daily trading volume, of 2,830,000 shares, the short-interest ratio is presently 1.9 days. Currently, 1.1% of the company's shares are short sold. View Baxter International's Current Options Chain.

Some companies that are related to Baxter International include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Steris (STE), Hologic (HOLX), Varian Medical Systems (VAR) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Johnson & Johnson (JNJ), Honeywell International (HON), Chipotle Mexican Grill (CMG), Micron Technology (MU), Pfizer (PFE), Cisco Systems (CSCO) and Verizon Communications (VZ).

Baxter International's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Veritas Asset Management LLP (1.25%), California Public Employees Retirement System (0.74%), Sumitomo Mitsui Trust Holdings Inc. (0.39%), Robeco Institutional Asset Management B.V. (0.36%), Haverford Trust Co. (0.22%) and SPF Beheer BV (0.20%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Veritas Asset Management LLP, State of New Jersey Common Pension Fund D, First Trust Advisors LP, Alberta Investment Management Corp, SG Americas Securities LLC, Gateway Investment Advisers LLC, Virginia Retirement Systems ET AL and Creative Planning. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was bought by a variety of institutional investors in the last quarter, including Kornitzer Capital Management Inc. KS, California Public Employees Retirement System, Teacher Retirement System of Texas, Dalton Greiner Hartman Maher & Co., State of Alaska Department of Revenue, Varma Mutual Pension Insurance Co, Meeder Asset Management Inc. and Railway Pension Investments Ltd. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $80.74.

Baxter International has a market capitalization of $41.22 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.View Additional Information About Baxter International.

The official website for Baxter International is http://www.baxter.com/.

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]